Identification of small molecule antagonists of the human mas-related gene-X1 receptor

Priya Kunapuli, Seungtaek Lee, Wei Zheng, Melissa Alberts, Oleg Kornienko, Rebecca Mull, Anthony Kreamer, Jong-Ik Hwang, Melvin I. Simon, Berta Strulovici

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The recently identified mas-related-gene (MRG) family of receptors, located primarily in sensory neurons of the dorsal root ganglion, has been implicated in the perception of pain. Thus, antagonists of this class of receptors have been postulated to be useful analgesics. Toward this end, we developed a cell-based beta-lactamase (BLA) reporter gene assay to identify small molecule antagonists of the human MRG-X1 receptor from a library of compounds. Single-cell clones expressing functional receptors were selected using the BLA reporter gene technology. The EC50 for the MRG agonist peptide, BAM15, appeared to be comparable between the BLA assay and the intracellular Ca2+ transient assays in these cells. Ultra high-throughput screening of approximately 1 million compounds in a 1.8-μl cell-based BLA reporter gene assay was conducted in a 3456-well plate format. Compounds exhibiting potential antagonist profile in the BLA assay were confirmed in the second messenger Ca2+ transient assay. A cell-based receptor trafficking assay was used to further validate the mechanism of action of these compounds. Several classes of compounds, particularly the 2,3-disubstituted azabicyclo-octanes, appear to be relatively potent antagonists at the human MRG-X1 receptors, as confirmed by the receptor trafficking assay and radioligand binding studies. Furthermore, the structure-activity relationship reveals that within this class of compounds, the diphenylmethyl moiety is constant at the 2-substituent, whereas the 3-substituent is directly correlated with the antagonist activity of the compound.

Original languageEnglish
Pages (from-to)50-61
Number of pages12
JournalAnalytical Biochemistry
Volume351
Issue number1
DOIs
Publication statusPublished - 2006 Apr 1
Externally publishedYes

Fingerprint

beta-Lactamases
Assays
Molecules
Reporter Genes
Genes
Benzhydryl Compounds
Octanes
Radioligand Assay
Pain Perception
Spinal Ganglia
Second Messenger Systems
Sensory Receptor Cells
Structure-Activity Relationship
Clone cells
Analgesics
Clone Cells
human mas-related gene-X1 receptor
Technology
Peptides
Neurons

Keywords

  • Azabicyclo-octanes
  • GFP
  • GPCRs
  • High-throughput screening
  • MRG-X1
  • Receptor trafficking
  • Reporter gene assay

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Kunapuli, P., Lee, S., Zheng, W., Alberts, M., Kornienko, O., Mull, R., ... Strulovici, B. (2006). Identification of small molecule antagonists of the human mas-related gene-X1 receptor. Analytical Biochemistry, 351(1), 50-61. https://doi.org/10.1016/j.ab.2006.01.014

Identification of small molecule antagonists of the human mas-related gene-X1 receptor. / Kunapuli, Priya; Lee, Seungtaek; Zheng, Wei; Alberts, Melissa; Kornienko, Oleg; Mull, Rebecca; Kreamer, Anthony; Hwang, Jong-Ik; Simon, Melvin I.; Strulovici, Berta.

In: Analytical Biochemistry, Vol. 351, No. 1, 01.04.2006, p. 50-61.

Research output: Contribution to journalArticle

Kunapuli, P, Lee, S, Zheng, W, Alberts, M, Kornienko, O, Mull, R, Kreamer, A, Hwang, J-I, Simon, MI & Strulovici, B 2006, 'Identification of small molecule antagonists of the human mas-related gene-X1 receptor', Analytical Biochemistry, vol. 351, no. 1, pp. 50-61. https://doi.org/10.1016/j.ab.2006.01.014
Kunapuli, Priya ; Lee, Seungtaek ; Zheng, Wei ; Alberts, Melissa ; Kornienko, Oleg ; Mull, Rebecca ; Kreamer, Anthony ; Hwang, Jong-Ik ; Simon, Melvin I. ; Strulovici, Berta. / Identification of small molecule antagonists of the human mas-related gene-X1 receptor. In: Analytical Biochemistry. 2006 ; Vol. 351, No. 1. pp. 50-61.
@article{f742be36941b4efe9a29d3cb2c7e0fd3,
title = "Identification of small molecule antagonists of the human mas-related gene-X1 receptor",
abstract = "The recently identified mas-related-gene (MRG) family of receptors, located primarily in sensory neurons of the dorsal root ganglion, has been implicated in the perception of pain. Thus, antagonists of this class of receptors have been postulated to be useful analgesics. Toward this end, we developed a cell-based beta-lactamase (BLA) reporter gene assay to identify small molecule antagonists of the human MRG-X1 receptor from a library of compounds. Single-cell clones expressing functional receptors were selected using the BLA reporter gene technology. The EC50 for the MRG agonist peptide, BAM15, appeared to be comparable between the BLA assay and the intracellular Ca2+ transient assays in these cells. Ultra high-throughput screening of approximately 1 million compounds in a 1.8-μl cell-based BLA reporter gene assay was conducted in a 3456-well plate format. Compounds exhibiting potential antagonist profile in the BLA assay were confirmed in the second messenger Ca2+ transient assay. A cell-based receptor trafficking assay was used to further validate the mechanism of action of these compounds. Several classes of compounds, particularly the 2,3-disubstituted azabicyclo-octanes, appear to be relatively potent antagonists at the human MRG-X1 receptors, as confirmed by the receptor trafficking assay and radioligand binding studies. Furthermore, the structure-activity relationship reveals that within this class of compounds, the diphenylmethyl moiety is constant at the 2-substituent, whereas the 3-substituent is directly correlated with the antagonist activity of the compound.",
keywords = "Azabicyclo-octanes, GFP, GPCRs, High-throughput screening, MRG-X1, Receptor trafficking, Reporter gene assay",
author = "Priya Kunapuli and Seungtaek Lee and Wei Zheng and Melissa Alberts and Oleg Kornienko and Rebecca Mull and Anthony Kreamer and Jong-Ik Hwang and Simon, {Melvin I.} and Berta Strulovici",
year = "2006",
month = "4",
day = "1",
doi = "10.1016/j.ab.2006.01.014",
language = "English",
volume = "351",
pages = "50--61",
journal = "Analytical Biochemistry",
issn = "0003-2697",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Identification of small molecule antagonists of the human mas-related gene-X1 receptor

AU - Kunapuli, Priya

AU - Lee, Seungtaek

AU - Zheng, Wei

AU - Alberts, Melissa

AU - Kornienko, Oleg

AU - Mull, Rebecca

AU - Kreamer, Anthony

AU - Hwang, Jong-Ik

AU - Simon, Melvin I.

AU - Strulovici, Berta

PY - 2006/4/1

Y1 - 2006/4/1

N2 - The recently identified mas-related-gene (MRG) family of receptors, located primarily in sensory neurons of the dorsal root ganglion, has been implicated in the perception of pain. Thus, antagonists of this class of receptors have been postulated to be useful analgesics. Toward this end, we developed a cell-based beta-lactamase (BLA) reporter gene assay to identify small molecule antagonists of the human MRG-X1 receptor from a library of compounds. Single-cell clones expressing functional receptors were selected using the BLA reporter gene technology. The EC50 for the MRG agonist peptide, BAM15, appeared to be comparable between the BLA assay and the intracellular Ca2+ transient assays in these cells. Ultra high-throughput screening of approximately 1 million compounds in a 1.8-μl cell-based BLA reporter gene assay was conducted in a 3456-well plate format. Compounds exhibiting potential antagonist profile in the BLA assay were confirmed in the second messenger Ca2+ transient assay. A cell-based receptor trafficking assay was used to further validate the mechanism of action of these compounds. Several classes of compounds, particularly the 2,3-disubstituted azabicyclo-octanes, appear to be relatively potent antagonists at the human MRG-X1 receptors, as confirmed by the receptor trafficking assay and radioligand binding studies. Furthermore, the structure-activity relationship reveals that within this class of compounds, the diphenylmethyl moiety is constant at the 2-substituent, whereas the 3-substituent is directly correlated with the antagonist activity of the compound.

AB - The recently identified mas-related-gene (MRG) family of receptors, located primarily in sensory neurons of the dorsal root ganglion, has been implicated in the perception of pain. Thus, antagonists of this class of receptors have been postulated to be useful analgesics. Toward this end, we developed a cell-based beta-lactamase (BLA) reporter gene assay to identify small molecule antagonists of the human MRG-X1 receptor from a library of compounds. Single-cell clones expressing functional receptors were selected using the BLA reporter gene technology. The EC50 for the MRG agonist peptide, BAM15, appeared to be comparable between the BLA assay and the intracellular Ca2+ transient assays in these cells. Ultra high-throughput screening of approximately 1 million compounds in a 1.8-μl cell-based BLA reporter gene assay was conducted in a 3456-well plate format. Compounds exhibiting potential antagonist profile in the BLA assay were confirmed in the second messenger Ca2+ transient assay. A cell-based receptor trafficking assay was used to further validate the mechanism of action of these compounds. Several classes of compounds, particularly the 2,3-disubstituted azabicyclo-octanes, appear to be relatively potent antagonists at the human MRG-X1 receptors, as confirmed by the receptor trafficking assay and radioligand binding studies. Furthermore, the structure-activity relationship reveals that within this class of compounds, the diphenylmethyl moiety is constant at the 2-substituent, whereas the 3-substituent is directly correlated with the antagonist activity of the compound.

KW - Azabicyclo-octanes

KW - GFP

KW - GPCRs

KW - High-throughput screening

KW - MRG-X1

KW - Receptor trafficking

KW - Reporter gene assay

UR - http://www.scopus.com/inward/record.url?scp=33644966300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644966300&partnerID=8YFLogxK

U2 - 10.1016/j.ab.2006.01.014

DO - 10.1016/j.ab.2006.01.014

M3 - Article

C2 - 16510108

AN - SCOPUS:33644966300

VL - 351

SP - 50

EP - 61

JO - Analytical Biochemistry

JF - Analytical Biochemistry

SN - 0003-2697

IS - 1

ER -